Klinik für Psychiatrie und Psychotherapie / Forschung / Drittmittelprojekte / Prof. Dr. med. Martin Walter - Drittmittelprojekte / Aktuelle
Aktuelle Drittmittelprojekte Prof. M. Walter
DFG:
- Stratification and augmentation of EEG neurofeedback in depression by monitoring dynamic brain states with simultaneous electroencephalography and magnetic resonance (EEG-fMRI); DFG; FKZ: WA 2673/10-1
- Effects of ghrelin administration on dopamine and effort; DFG; WA 2673/15-1
BMBF:
- Cell-o: Ein smarter Stress Coach zur Krankheitsprävention; BMBF funding measure: Adaptive Technologien für die Gesellschaft - intelligentes Zusammenwirken von Mensch und KI; promoter: VDI/VDE Innovation + Technik GmbH, FKZ: 16SV8590
- DZPG - Deutsches Zentrum für Psychische Gesundheit; FKZ: 01EE2103
EU:
- NeuroMarKet: Neuroimaging and Blood Markers as Indicators of Ketamine Efficacy in Treatment Resistant Depression; BMBF-EU-EraNet-Neuron, FKZ: 01EW2010A
- ERA Net – SuppHab: Improvement of treatment resistant depression by suppression of lateral habenula activity
- Multimodal Imaging for Correlates of Abnormal Glutamatergic and GABAergic Neurotransmission in MDD Patients, Marie Curie Initial Training Network, r’BIRTH consortium
Industrie:
- Research Agreement Analysen (Neurim); Biologische Heilmittel Heel GmbH; (seit 01.12.2019; 61.00,00 €)
- PCN
- RestoreLife
- Heel INSOMNIA
- Ketabon
Andere:
Gene-environment interaction of Childhood Trauma and GAD polymorphism on neural mechanisms of emotion regulation, Fortune grant, University Tuebingen, 2394-0-0
Treatment augmentation by ketamine in Treatment resistant
depression; AKF grant, University Tübingen, 427-0-0